In-Vitro Lung Model Market Report 2026

In-Vitro Lung Model Market Overview

• In-Vitro Lung Model market size has reached to $0.54 billion in 2025 • Expected to grow to $1.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.6% • Growth Driver: Increasing Clinical Studies Propel Growth Of In Vitro Lung Model Market • Market Trend: Advancements in 3D Respiratory Tissue Models • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under In-Vitro Lung Model Market?

An In-Vitro lung model is a scientific construct designed to imitate the cellular, structural, and functional properties of the human lung in a controlled laboratory environment. These models enable researchers to investigate illness development, discover biomarkers, and assess treatment efficacy. They are useful tools for better understanding lung biology, developing therapies, and improving health outcomes. The main types of in vitro lung model are two-dimensional (2D) model and three-dimensional (3D) model. A 2D model is a simplified representation of lung cells and tissue on a flat surface that is used in basic research and the initial testing of substances. They are used for various applications including drug discovery and toxicology studies, physiological research, three-dimensional (3D) model development, and others by academic research institutes, pharmaceutical and biotechnology companies, and others.

What Is The In-Vitro Lung Model Market Growth Forecast?

The in-vitro lung model market size is expected to see rapid growth in the next few years. It will grow to $1.29 billion in 2030 at a compound annual growth rate (CAGR) of 18.6%. The growth in the forecast period can be attributed to rising demand for predictive preclinical lung models, increasing focus on reducing animal testing, expansion of respiratory drug development pipelines, growing investment in advanced in-vitro research tools, demand for more physiologically relevant lung disease models. Major trends in the forecast period include increasing adoption of three-dimensional lung models in drug research, growing use of lung-on-a-chip platforms for disease modeling, rising preference for human-relevant in-vitro lung testing systems, expansion of in-vitro lung models in toxicology and safety studies, greater integration of in-vitro lung models in preclinical research pipelines.

Global In-Vitro Lung Model Market Segmentation

1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model 2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications 3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures 2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models

What Is The Driver Of The In-Vitro Lung Model Market?

The increase in clinical studies is expected to propel the growth of the in vitro lung model market going forward. Clinical studies refer to research investigations conducted to evaluate the safety, effectiveness, and outcomes of new medical treatments, drugs, or diagnostic tools in humans. The number of clinical studies is rising due to growing healthcare needs, increased demand for advanced medical treatments, and the pursuit of innovative solutions for complex health conditions. The in vitro lung model market supports clinical research by offering controlled systems that enable drug testing, toxicity evaluation, disease modeling, and analysis of lung-specific biological responses. For instance, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, there were 477,230 registered clinical trials globally by the end of 2023, an increase from the 437,508 trials recorded in 2022. Therefore, the increase in clinical studies is driving the in vitro lung model market.

Key Players In The Global In-Vitro Lung Model Market

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH

Global In-Vitro Lung Model Market Trends and Insights

Major companies operating in the in vitro lung model market are focusing on developing advanced 3D respiratory tissue models to improve physiological relevance, enhance predictive accuracy, and strengthen preclinical testing capabilities. A 3D respiratory tissue model refers to a laboratory-grown three-dimensional structure composed of primary or specialized respiratory cells cultured in conditions that allow them to mimic the architecture and function of human airway tissues, including mucus production, ciliary movement, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, introduced EpiNasal, a 3D respiratory tissue model created from primary human nasal epithelial cells that replicates functional features of nasal epithelium such as goblet cells, active tight junctions, and beating cilia, providing researchers with a highly relevant platform for evaluating the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.

What Are Latest Mergers And Acquisitions In The In-Vitro Lung Model Market?

In July 2024, Tergus Pharma, a US-based end-to-end service provider for topical pharmaceutical products, merged with MedPharm Ltd. for an undisclosed amount. This merger strengthens Tergus Pharma’s integrated development and manufacturing capabilities by combining MedPharm’s expertise in formulation development, in vitro performance testing, and human-tissue–based delivery models with Tergus’s commercial production and serialization strengths. It further enhances the organization’s ability to develop and manufacture hormone-based and highly potent drugs through expanded GMP capacity at its Durham, NC facility. MedPharm Ltd. is a UK-based provider of in vitro models that simulate lung and nasal drug-delivery systems.

Regional Insights

North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the In-Vitro Lung Model Market?

The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the In-Vitro Lung Model Market Report 2026?

The in-vitro lung model market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro lung model industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.